“…Indeed, CNV arrays and MLPA are often used sequentially; MLPA is frequently utilized to confirm CNV array results, determine the mode of inheritance, and screen patient cohorts for known CNVs which in turn are then fine-mapped using CNV arrays [White et al, , 2012Kim et al, 2015;Ohnesorg et al, 2017]. MLPA can also be used to detect CNVs of single exons in genes of interest [Barbaro et al, 2011]; however, due to the expense of CGD, complete gonadal dysgenesis; GD, gonadal dysgenesis; OT, ovotesticular DSD the probes, this would only be cost-effective if large cohorts were screened for particular well-known candidate genes.…”